Purpose | Patients | Evaluations | Perceived Effectiveness |
---|---|---|---|
Atopic dermatitis | 53 | 0 | |
Psoriasis | 3 | 1 | |
Eczema | 2 | 0 | |
Keratosis pilaris | 1 | 0 |
Side effect severity
Severity | Evaluations | Percentage |
---|---|---|
Severe | 0 | |
Moderate | 0 | |
Mild | 0 | |
None | 1 |
Purpose | Patients | Evaluations | Perceived Effectiveness |
---|---|---|---|
Atopic dermatitis | 53 | 0 | |
Psoriasis | 3 | 1 | |
Eczema | 2 | 0 | |
Keratosis pilaris | 1 | 0 |
Severity | Evaluations | Percentage |
---|---|---|
Severe | 0 | |
Moderate | 0 | |
Mild | 0 | |
None | 1 |